Healthcare provider profile · identity verified

Alyssa Jo Stickney, MD

Family Practice · MONROE, WA · NPI 1558490102

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	429	106
Losartan Potassium	Losartan Potassium	250	62
Levothyroxine Sodium	Levothyroxine Sodium	245	60
Lisinopril	Lisinopril	198	51
Gabapentin	Gabapentin	165	46
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	162	29
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	141	19
Amlodipine Besylate	Amlodipine Besylate	140	38
Omeprazole	Omeprazole	123	35
Trazodone Hcl	Trazodone Hcl	120	34
Metformin Hcl Er	Metformin Hcl	108	30
Rosuvastatin Calcium	Rosuvastatin Calcium	106	26
Hydrochlorothiazide	Hydrochlorothiazide	102	30
Metoprolol Succinate	Metoprolol Succinate	101	29
Sertraline Hcl	Sertraline Hcl	101	24
Albuterol Sulfate Hfa	Albuterol Sulfate	95	38
Atenolol	Atenolol	75	15
Simvastatin	Simvastatin	70	17
Furosemide	Furosemide	67	18
Clopidogrel	Clopidogrel Bisulfate	61	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	61	17
Metformin Hcl	Metformin Hcl	61	17
Oxycodone Hcl	Oxycodone Hcl	55	11
Fluticasone Propionate	Fluticasone Propionate	52	24
Venlafaxine Hcl Er	Venlafaxine Hcl	51	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	49	18
Estradiol	Estradiol	48	18
Acetaminophen-Codeine	Acetaminophen With Codeine	45	suppressed
Lorazepam	Lorazepam	45	16
Carvedilol	Carvedilol	43	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	43	14
Tamsulosin Hcl	Tamsulosin Hcl	42	11
Citalopram Hbr	Citalopram Hydrobromide	40	suppressed
Alprazolam	Alprazolam	39	suppressed
Enalapril Maleate	Enalapril Maleate	39	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	38	suppressed
Montelukast Sodium	Montelukast Sodium	36	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	35	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	35	suppressed
Bupropion Xl	Bupropion Hcl	34	11
Mounjaro	Tirzepatide	34	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	33	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	33	suppressed
Pregabalin	Pregabalin	32	suppressed
Baclofen	Baclofen	31	suppressed
Buspirone Hcl	Buspirone Hcl	31	suppressed
Eliquis	Apixaban	31	13
Glipizide Er	Glipizide	31	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	31	suppressed
Ozempic	Semaglutide	31	suppressed
Potassium Chloride	Potassium Chloride	30	11
Synthroid	Levothyroxine Sodium	30	suppressed
Chlorthalidone	Chlorthalidone	29	suppressed
Pravastatin Sodium	Pravastatin Sodium	29	suppressed
Tramadol Hcl	Tramadol Hcl	29	suppressed
Alendronate Sodium	Alendronate Sodium	27	suppressed
Spironolactone	Spironolactone	27	suppressed
Duloxetine Hcl	Duloxetine Hcl	24	11
Ondansetron Odt	Ondansetron	24	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	23	suppressed
Prednisone	Prednisone	23	16
Famotidine	Famotidine	22	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	22	suppressed
Tizanidine Hcl	Tizanidine Hcl	22	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	suppressed
Ropinirole Hcl	Ropinirole Hcl	21	suppressed
Memantine Hcl	Memantine Hcl	20	suppressed
Lovastatin	Lovastatin	19	suppressed
Valacyclovir	Valacyclovir Hcl	19	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	18	13
Meloxicam	Meloxicam	18	suppressed
Morphine Sulfate Er	Morphine Sulfate	18	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	18	11
Trulicity	Dulaglutide	18	suppressed
Glipizide	Glipizide	17	suppressed
Rizatriptan	Rizatriptan Benzoate	17	suppressed
Jardiance	Empagliflozin	16	suppressed
Mirtazapine	Mirtazapine	16	suppressed
Allopurinol	Allopurinol	15	suppressed
Azelastine Hcl	Azelastine Hcl	15	suppressed
Bydureon Bcise	Exenatide Microspheres	15	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	15	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	15	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	15	suppressed
Topiramate	Topiramate	15	suppressed
Acyclovir	Acyclovir	14	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	14	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Meclizine Hcl	Meclizine Hcl	14	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	14	suppressed
Novolog Flexpen	Insulin Aspart	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Asenapine Maleate	Asenapine Maleate	13	suppressed
Finasteride	Finasteride	13	suppressed
Lamotrigine	Lamotrigine	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Risperidone	Risperidone	13	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	13	suppressed
Arnuity Ellipta	Fluticasone Furoate	12	suppressed
Atrovent Hfa	Ipratropium Bromide	12	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	12	suppressed
Spiriva Handihaler	Tiotropium Bromide	12	suppressed
Varenicline Tartrate	Varenicline Tartrate	12	suppressed
Vyvanse	Lisdexamfetamine Dimesylate	12	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Glimepiride	Glimepiride	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error